Literature DB >> 16145084

Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS.

Xiang Y Han1, Jeffrey J Tarrand, Rosa Infante, Kalen L Jacobson, Mylene Truong.   

Abstract

The clinical significance and prevalence of Mycobacterium avium and Mycobacterium intracellulare were analyzed in a cohort of 7,472 patients who, from 1999 to 2003, sought care at the University of Texas M.D. Anderson Cancer Center, Houston, and had cultures performed for mycobacteria. Patients were stratified for age, sex, and underlying diseases, and bacteria were identified by 16S rRNA gene sequencing. M. avium was isolated in 62 (0.83%) of 7,472 patients and M. intracellulare in 65 (0.87%). Clinically, only 10 of the 62 (16.2%) patients with M. avium had probable to definite evidence of infection, whereas the majority (83.8%) had weak evidence of infection. Sex and age did not affect the isolation or infection of M. avium. Hematological tumors predisposed to M. avium colonization but not infection. In contrast, 41 of the 65 (63.1%) patients with M. intracellulare had probable to definite infection, a level much higher than those with M. avium (P < 0.001). M. intracellulare was more prevalent in women (1.33% of 3,311) than in men (0.50% of 4,161) (P < 0.001), and underlying diseases had no effect in women. Men with lung cancer had a higher prevalence (1.37%) than men without (0.34%) (4.0-fold; P < 0.001), but it was similar to that in women. A marked age trend for the isolation of M. intracellulare among women was noted: 0.27% (1-fold) for ages of <50 years, 0.85% (3.1-fold) for ages 50 to 59 years, 1.50% (5.6-fold) for ages 60 to 69 years, and 3.74% (13.9-fold) for ages >/=70 years (trend, P < 0.001). The combined rate for women >/=50 was 1.86% (95% confidence interval [1.30 to 2.42%]) (6.9-fold). Together, these results suggest that, among non-AIDS patients, M. intracellulare is more pathogenic and tends to infect women increasingly beyond menopause (age >/=50 years) regardless of underlying disease. The prevalence rate of 1.86% in postmenopausal women suggests the need to further investigate the public health significance of M. intracellulare.

Entities:  

Mesh:

Year:  2005        PMID: 16145084      PMCID: PMC1234053          DOI: 10.1128/JCM.43.9.4407-4412.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species.

Authors:  C Y Turenne; L Tschetter; J Wolfe; A Kabani
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Bacterial communication: tiny teamwork.

Authors:  E Peter Greenberg
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

3.  Differentiation of Mycobacterium species by direct sequencing of amplified DNA.

Authors:  T Rogall; T Flohr; E C Böttger
Journal:  J Gen Microbiol       Date:  1990-09

4.  Mycobacterium avium complex lung disease in immunocompetent patients: radiography-CT correlation.

Authors:  C Wittram; G L Weisbrod
Journal:  Br J Radiol       Date:  2002-04       Impact factor: 3.039

5.  Isolation of nontuberculous mycobacteria in the United States, 1980.

Authors:  R C Good; D E Snider
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

6.  Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice.

Authors:  K Tsuyuguchi; K Suzuki; H Matsumoto; E Tanaka; R Amitani; F Kuze
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

7.  Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis.

Authors:  Richard J Wallace; Yansheng Zhang; Barbara A Brown-Elliott; Mitchell A Yakrus; Rebecca W Wilson; Linda Mann; Leslie Couch; William M Girard; David E Griffith
Journal:  J Infect Dis       Date:  2002-06-25       Impact factor: 5.226

Review 8.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease.

Authors:  K Kubo; Y Yamazaki; T Hachiya; M Hayasaka; T Honda; M Hasegawa; S Sone
Journal:  Lung       Date:  1998       Impact factor: 2.584

10.  Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.

Authors:  R J Wallace; Y Zhang; B A Brown; D Dawson; D T Murphy; R Wilson; D E Griffith
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

View more
  33 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Distribution of hsp65 PCR-restriction enzyme analysis patterns among Mycobacterium avium complex isolates in Thailand.

Authors:  Therdsak Prammananan; Saranya Phunpruch; Nipa Tingtoy; Somboon Srimuang; Angkana Chaiprasert
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

3.  Subspecies identification and significance of 257 clinical strains of Mycobacterium avium.

Authors:  Quynh T Tran; Xiang Y Han
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

4.  Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.

Authors:  Devyani Deshpande; Shashikant Srivastava; Claudia Meek; Richard Leff; Gerri S Hall; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

5.  Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.

Authors:  Theodore K Marras; Mauli Mehta; Pamela Chedore; Kevin May; Mohammed Al Houqani; Frances Jamieson
Journal:  Lung       Date:  2010-04-11       Impact factor: 2.584

Review 6.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

7.  Concurrent Cultivation of Mycobacterium avium and Mycobacterium intracellulare Identified by a Single Sanger Sequencing of the 16S Gene.

Authors:  Xiang Y Han; Mohammad A Golshan; Christopher J Bowman
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

8.  Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.

Authors:  Seong Mi Moon; Hye Yun Park; Su-Young Kim; Byung Woo Jhun; Hyun Lee; Kyeongman Jeon; Dae Hun Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Seung-Heon Lee; Chang Ki Kim; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Variable-number tandem-repeat markers for typing Mycobacterium intracellulare strains isolated in humans.

Authors:  Frédéric-Antoine Dauchy; Sébastien Dégrange; Alain Charron; Michel Dupon; Yi Xin; Cécile Bébéar; Jeanne Maugein
Journal:  BMC Microbiol       Date:  2010-03-29       Impact factor: 3.605

10.  Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.

Authors:  Mehdi Mirsaeidi; Walid Hadid; Basel Ericsoussi; Daniel Rodgers; Ruxana T Sadikot
Journal:  Int J Infect Dis       Date:  2013-05-16       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.